BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
2.040
-0.130 (-5.99%)
At close: Nov 6, 2026, 4:00 PM EST
2.080
+0.040 (1.96%)
After-hours: Nov 6, 2026, 7:48 PM EST
BBOT's stock price has decreased by -83.55% in the past year and price targets may not have had time to catch up.
BBOT Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $21 | Buy | Maintains | $21 | +929.41% | Oct 26, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $13 | Buy | Maintains | $13 | +537.25% | Oct 21, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $22 → $16 | Buy | Maintains | $22 → $16 | +684.31% | Oct 20, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $27 → $25 | Buy | Reiterates | $27 → $25 | +1,125.49% | Sep 18, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 15, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $25 | Buy | Maintains | $25 | +1,125.49% | Sep 9, 2026 |
| Raymond James | Raymond James | Buy Maintains $24 → $22 | Buy | Maintains | $24 → $22 | +978.43% | Sep 9, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $23 → $15 | Buy | Maintains | $23 → $15 | +635.29% | Sep 9, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.